Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Aquestive Therapeutics, Inc. (AQST) vs Evotec AG (EVO)

Aquestive Therapeutics, Inc. and Evotec AG are both Drug Manufacturers Specialty & Generic companies. Aquestive Therapeutics, Inc. is the larger, with a market value of $605.0M against $539.9M — 1.1× the size. Aquestive Therapeutics, Inc. grew revenue faster over the last twelve months: 22.6% against 2.15%. Evotec AG has the higher net margin (−26.2% vs −144.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Evotec AG leads on 9 and Aquestive Therapeutics, Inc. on 7.

Valuation

Metric AQST EVO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S 10.82 0.64 2.25
P/B n/m 0.72 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales 9.93 0.65 2.56
Earnings yield (13.89%) (40.90%) (2.99%)
Free cash flow yield (7.85%) (36.14%) 0.00%

Profitability

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Gross margin 67.04% 11.42% 53.94%
Operating margin (97.52%) (21.35%) 0.00%
Net margin (144.63%) (26.20%) 0.00%
Free cash flow margin (84.95%) 0.00% 0.00%
Return on equity 121.12% 0.00% (0.40%)
Return on assets (69.29%) 0.00% (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 22.56% 2.15% 10.01%
EPS growth (last fiscal year) (52.94%) 44.89% —
Revenue growth, 5-year CAGR (0.58%) 9.28% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) 0.72 0.05
Current ratio 7.19 2.33 2.31
Net debt to EBITDA 1.57 (0.64) 0.85

Dividend

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AQST EVO Drug Manufacturers Specialty & Generic median
Market cap 604.97m 539.87m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack